Cancer Research Institute: Clinical Innovator
Research Admin Offices:
- HRS
Funding Type:
GrantOpportunity Type:
- Grant
Value:
Up to $1,000,000 US per trial.
Disciplines:
- Health Sciences
Sponsors:
Deadlines:
Internal Deadline:
November 17, 2025Sponsor Deadline:
April 4, 2026Additional Dates:
- HRS Protocol Due Date - November 17, 2025
- Sponsor Protocol Due Date - December 1, 2025
- Sponsor Application Due Date (by invitation) - April 4, 2026
Description:
This opportunity supports novel clinical studies that address areas of high unmet need in cancer and seek mechanistic insights into clinical response with a goal of predictive biomarker discovery.
Resources:
Contact:
If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.